Literature DB >> 31715245

Safety evaluation of silver-ion dressings in a porcine model of deep dermal wounds: A GLP study.

David J Barillo1, Claire R Croutch2, Anthony R Barillo3, Frances Reid2, Al Singer4.   

Abstract

INTRODUCTION: Silver ion has strong antimicrobial properties and is used in a number of wound dressings. In burn models, silver-nylon dressings produce elevated silver levels in the wound along with minimal systemic effect. We evaluated systemic toxicity in a non-burn wound model to see if a similar pattern of silver ion distribution would occur.
METHODS: Eight deep partial-thickness wounds each were created on the dorsum of 40 Gottingen minipigs using a Er-YAG Laser. Half were treated with a 21-day course of silver-nylon dressings (Silverlon®) and half were treated with moist gauze dressings. Wound, blood, liver and kidney silver levels, along with blood chemistry and hematology data were obtained at appropriate intervals.
RESULTS: All wounds healed well with healing enhanced by silver-nylon dressings. Silver ion was demonstrable in all wounds treated with silver-nylon at day 21 and after 14 days of no further treatment. Silver ion was not detected in blood, liver or kidney of any animal treated with silver-nylon or control dressings. Liver and kidney function remained normal in all animals.
CONCLUSION: A 21-day application of silver-nylon dressings to a non-burn dermal wound produces no systemic or local toxicity in Gottingen minipigs.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Laser; Silver; Silver nylon; Wound

Mesh:

Substances:

Year:  2019        PMID: 31715245     DOI: 10.1016/j.toxlet.2019.10.023

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  1 in total

1.  Application Effect of Silver-Containing Dressings in the Repair of Chronic Refractory Wounds.

Authors:  Rui Wang; Yuan Guo; Bao Li; Jingjing Zheng; Zhishui Tang; Maoguo Shu
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-10       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.